STAT3-dependent transcription has been associated with the progression of multiple cancers, including PDAC.5,6 Notably, elevated levels of JAK-STAT3 signaling are associated with pancreatic cancer, and STAT3 activity has been reported to drive tumor initiation, progression, and therapeutic resistance in PDAC.7,8. Here, STAT3 is linked to familial pancreatic carcinoma.